Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View AllMSN features Dr. Kurt Kroenke
Kurt Kroenke, M.D., was featured by MSN.com for his study...
Influence
View AllEffectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years – VISION Network, United States, July 2022-June 2023
Published in the journal Morbidity and Mortality Weekly Report. Here...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
February 22, 2023
Dr. Boustani in Clinical Research News
"*" indicates required fields